Results 261 to 270 of about 863,504 (313)
Some of the next articles are maybe not open access.

Bone histomorphometry and bone quality

Osteoporosis International, 2009
Although PTH(1–34) and PTH are now approved as anabolic therapies for osteoporosis, much remains to be learned about their mechanisms of action and how they interact with antiresorptive agents. In 1995, Pierre Delmas and his colleagues published a landmark paper [1] in which histomorphometric analysis was used to explore the effects of combined ...
D W, Dempster   +2 more
openaire   +2 more sources

Bone and Bone Healing

Veterinary Clinics of North America: Small Animal Practice, 1999
Bone is composed of cells and organic matrix (30%), and minerals (70%). A vascular network consisting of nutrient, metaphyseal, and periosteal vessels richly supplies adult bone. Fracture healing consists of three interrelated phases: inflammatory, repair, and remodeling, and culminates in the ability of bone to return to original tissue structure ...
openaire   +2 more sources

Bone Deficit and Bone Health

Nutrition in Clinical Practice, 2007
cover a broad range of clinical situations that pre-dispose the patient to bone deficit, such as criticalcare, prolonged parenteral nutrition (PN), treat-ment in rehabilitation programs, and patients withestablished osteoporosis. Many of the articles alsoincorporate state of the art recommendations tooptimize vitamin D and calcium status.The critical ...
openaire   +2 more sources

Bone densitometry and bone biopsy

Best Practice & Research Clinical Rheumatology, 2005
Bone densitometry is one of the most frequently used investigations in the assessment and management of patients suspected to have osteoporosis. The current method of choice for measuring BMD is dual-energy X-ray absorptiometry, because of its high precision and low radiation dose. The initiation and choice of treatment in patients with osteoporosis is
openaire   +2 more sources

Bone and Bone Turnover

2009
Children with cancer are exposed to multiple influences that may adversely affect bone health. Some treatments have direct deleterious effects on bone whilst others may have indirect effects mediated through various endocrine abnormalities. Most clinical outcome studies have concentrated on survivors of acute lymphoblastic leukaemia (ALL). There is now
openaire   +2 more sources

Bone and Bone Graft Healing

Oral and Maxillofacial Surgery Clinics of North America, 2007
Bone is unique in connective tissue healing because it heals entirely by cellular regeneration and the production of a mineral matrix rather than just collagen deposition known as scar. This article discusses the cellular, tissue, and organ levels in each of the following sections--skeletal embryology, normal bone, examples of abnormal bone, and bone ...
openaire   +2 more sources

Bone Grafts and Bone Induction Substitutes

Clinics in Plastic Surgery, 1994
The use of bone grafts is the basis of all craniofacial surgery. Bone grafts are used to stabilize the open segments, expand the patient's structural boundaries, and fill defects created by trauma or congenital malformations. Bone grafts are harvested from local or distant sites as indicated. Biomaterial implants are used as bone substitutes when it is
M B, Habal, A H, Reddi
openaire   +2 more sources

Bone, bone marrow, and brain oxygen

American Journal of Physiology-Legacy Content, 1962
Oxygen availability (aO2) was measured polarographically in bone, bone marrow, and brains of cats. Immediately after electrodes had been implanted, the mean bone marrow oxygen was erratic. It reached a maximum around the 12th postoperative day, then decreased to a stable level within 2–3 months.
G A, MISRAHY   +4 more
openaire   +2 more sources

High bone density and bone health

Endocrinología y Nutrición (English Edition), 2012
The aim of this paper is to review the main aspects related to high bone density (HBD) as well as to discuss the physiologic mechanisms involved in bone health. There are still no well-defined criteria for identification of individuals with HBD and there are few studies on the topic.
Karin Sedó, Sarkis   +3 more
openaire   +2 more sources

Bone resorption and bone metastasis risk

Medical Hypotheses, 2018
Breast cancer tumors have a tendency to metastasize to the bone. After development of a bone metastasis, the median survival time is 40 months. Currently, little is known about the modifiable risk factors for developing bone metastases in women diagnosed with breast cancer. One possible modifiable risk factor is increased bone resorption.
Katlynn M, Mathis   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy